heartlab My Heart Project

Continuously-worn ECG patch

A miniature rechargeable chest patch with two dry/gel electrodes for single-lead ECG in continuous-wear mode for up to 30 days without recharging. Data is sent over BLE to a single dedicated app. Target volume โ€” from 10,000 units.

ECG patch

Architecture

flowchart LR
  subgraph FE["Analog front-end"]
    E1((Electrode 1))
    E2((Electrode 2))
    AFE["MAX30003
ECG AFE
+ R-peak HW detect"] end MCU["nRF52810/811
Cortex-M4 + BLE 5.x"] subgraph SENS["Sensors & memory"] ACC["LIS2DW12
Accelerometer"] FLASH["W25Q* SPI NOR
4-8 MB buffer
for BLE dropout"] end subgraph PWR["Power"] BAT[("LiPo
100-150 mAh")] PMIC["MAX77658
charger + LDO
+ fuel gauge"] DOCK["USB-C or
pogo-pin dock"] end PHONE["๐Ÿ“ฑ heartlab.app"] E1 --> AFE E2 --> AFE AFE -->|"SPI + IRQ"| MCU MCU <-->|"IยฒC"| ACC MCU <-->|"SPI"| FLASH MCU <-->|"BLE 5.x"| PHONE BAT --> PMIC DOCK -.-> PMIC PMIC -->|"power"| AFE PMIC -->|"power"| MCU PMIC -->|"power"| ACC PMIC -->|"power"| FLASH

Key component choices

โ€” MAX30003 โ€” the de-facto irreplaceable chip today: a specialized single-channel AFE for wearable ECG. Biopotential input, ADC, filtering, R-peak detection and RR-interval computation, lead-off detection โ€” all implemented in silicon at a power level unattainable if the same tasks were solved with discrete electronics and an MCU.

โ€” nRF52810/811 โ€” Nordic MCU, optimized for miniature BLE devices.

โ€” LIS2DW12 โ€” accelerometer chip, strongly recommended for motion-artifact rejection.

โ€” SPI flash buffer โ€” data-buffering chip for when there is no phone connection for more than a few minutes.

Power budget

30 days (720 h), data transfer no more than every 30 s, no real-time streaming

Component / modeCurrent
MAX30003 streaming85 ยตA
nRF52 sleep (RTC)1.5 ยตA
nRF52 BLE TX (~50 ms every 30 s)8.5 ยตA
LIS2DW12 low-power1 ยตA
Average total95โ€“100 ยตA

Required battery 100โ€“130 mAh, LiPo 5ร—20ร—3 mm, ~3 g.

โœ“ Goal of a month without recharging โ€” looks achievable

Cost estimate

10k+ volume, FOB Shenzhen

Item$
MAX30003 (specialized, expensive)7.0
nRF52810 (alt: EFR32MG22)2.0
LIS2DW120.4
SPI NOR flash 4 MB0.3
LiPo 100โ€“130 mAh1.8
PCB 4-layer flex-rigid + assembly2.0
Ag/AgCl electrodes + adhesive base1.2
Enclosure (injection molding)1.8
MAX77658 (charger, LDO, fuel gauge)3.0
Passives, antenna, connectors0.5
Total cost of goods20

The battery can be replaced with primary cells โ€” this cuts cost and removes the charging circuit, but creates enclosure-sealing problems.

โœ“ Goal of $15โ€“20 cost of goods โ€” looks achievable

Note. At retail the consumer price likely rises to ~$70, because the following is added:
assembly + test + packaging ร—1.3$26
manufacturer margin (20%, unless the project is charity)$31
logistics, warehousing, warranty$35
retail markup ร—2 (stores)$70

Not yet counted: R&D, certification (if required), marketing, reverse logistics.

โœ— Goal of a $15โ€“20 final consumer price โ€” unachievable

Other considerations and risks

Key baseline questions

Proposed stages, optimistic cost and timeline

Development requires a coordinated team of 2โ€“3 qualified engineers experienced in building devices of this level (available).

Phase 1. Preparation, experiments, measurements, detailing4 wks ยท โ‚ฌ15โ€“20k
Goal
Prove the chosen architecture can measure RR with two electrodes at acceptable autonomy.
Work
Analysis of the MAX30003 and its pairing with the Nordic MCU; prototype schematic; input-path breadboard; basic BLE firmware; receiving RR from the MAX30003 and a raw ECG stream for debugging; power-consumption measurement; testing 2 vs 3 electrodes; initial trials on a few volunteers.
Result
Working breadboard; ECG graphs; RR stream into a test utility; signal-quality report; power-consumption report; recommendation on further architecture.
Phase 2. Engineering prototype (enclosure โ€” 3D-printed)10 wks ยท โ‚ฌ30โ€“50k
Goal
Build a compact board and enclosure close to the real device.
Work
Miniature PCB; power optimization; enclosure design; electrode-sticker design; BLE protocol with authorization; debugging and OTA reflashing; autonomy testing; motion testing; pilot-batch preparation.
Result
10 engineering samples; documentation; firmware; a test demo app (for later integration of its protocols into the target app); a report on problems and limitations.
Phase 3. Pilot batch: DVT prototype, 50 units (enclosure โ€” injection molding)12 wks ยท โ‚ฌ60โ€“100k
Additionally
One-time injection mold for all subsequent enclosures: โ‚ฌ15โ€“40k.
Goal
Verify manufacturing reproducibility and user scenarios.
Work
DFM/DFT analysis; production tests; batch assembly; field trials; failure-statistics collection; BOM refinement; series-version preparation.
Result
Pilot batch; reliability report; final changes before mass production.
Total full cycle to mass-production readiness (without medical certification): 9 months (optimistic; realistically 1 year), budget โ‚ฌ105โ€“170k (+ cost of the injection mold for further enclosure production).